The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers

Background Unresolved issues with propofol include whether the pharmacokinetics are linear with dose, are influenced by method of administration (bolus vs. infusion), or are influenced by age. Recently, a new formulation of propofol emulsion, containing disodium edetate (EDTA), was introduced in the United States. Addition of EDTA was found by the manufacturer to significantly reduce bacterial growth. This study investigated the influences of method of administration, infusion rate, patient covariates, and EDTA on the pharmacokinetics of propofol. Methods Twenty‐four healthy volunteers aged 26–81 yr were given a bolus dose of propofol, followed 1 h later by a 60‐min infusion. Each volunteer was randomly assigned to an infusion rate of 25, 50, 100, or 200 micro gram [center dot] kg‐1 [center dot] min‐1. Each volunteer was studied twice under otherwise identical circumstances: once receiving propofol without EDTA and once receiving propofol with EDTA. The influence of the method of administration and of the volunteer covariates was explored by fitting a three‐compartment mamillary model to the data. The influence of EDTA was investigated by direct comparison of the measured concentrations in both sessions. Results The concentrations of propofol with and without EDTA were not significantly different. The concentration measurements after the bolus dose were significantly underpredicted by the parameters obtained just from the infusion data. The kinetics of propofol were linear within the infusion range of 25–200 micro gram [center dot] kg‐1 [center dot] min‐1. Age was a significant covariate for Volume2 and Clearance2, as were weight, height, and lean body mass for the metabolic clearance. Conclusions These results demonstrate that method of administration (bolus vs. infusion), but not EDTA, influences the pharmacokinetics of propofol. Within the clinically relevant range, the kinetics of propofol during infusions are linear regarding infusion rate.

[1]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[2]  A. Schilling,et al.  Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia; report of two cases with autopsy findings. , 1955, The New England journal of medicine.

[3]  J. Kitchell,et al.  THE LONG TERM USE, SIDE EFFECTS, AND TOXICITY OF DISODIUM ETHYLENEDIAMINE TETRAACETIC ACID (EDTA) , 1961, The American journal of the medical sciences.

[4]  L B Sheiner,et al.  Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.

[5]  L B Sheiner,et al.  Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. , 1982, Journal of pharmaceutical sciences.

[6]  E. Gepts,et al.  Disposition of Propofol Administered as Constant Rate Intravenous Infusions in Humans , 1987, Anesthesia and analgesia.

[7]  V Maes,et al.  Disposition kinetics of propofol during alfentanil anaesthesia , 1988, Anaesthesia.

[8]  E. J. Douglas,et al.  Pharmacokinetics of propofol (diprivan) in elderly patients. , 1988, British journal of anaesthesia.

[9]  P. Kempen Contamination of syringes , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[10]  J T Harvey,et al.  Computer controlled infusion of propofol. , 1989, British journal of anaesthesia.

[11]  H. Sonntag,et al.  Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery. , 1990, British journal of anaesthesia.

[12]  M. Avram,et al.  The relationship of age to the pharmacokinetics of early drug distribution: the concurrent disposition of thiopental and indocyanine green. , 1990, Anesthesiology.

[13]  D R Stanski,et al.  Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. , 1990, Anesthesiology.

[14]  S. McAllister,et al.  Microbial Growth and Endotoxin Production in the Intravenous Anesthetic Propofol , 1991, Infection Control & Hospital Epidemiology.

[15]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[16]  Steven L. Shafer,et al.  Effects of age on propofol pharmacokinetics , 1992 .

[17]  C A Shanks,et al.  Minimal compartmental model of circulatory mixing of indocyanine green. , 1992, The American journal of physiology.

[18]  B. Braverman,et al.  Growth of Staphylococcus aureus in Four Intravenous Anesthetics , 1993 .

[19]  J. Glen,et al.  Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. , 1994 .

[20]  B. Marshall,et al.  Fentanyl and propofol uptake by the lung: effect of time between injections , 1994, Acta anaesthesiologica Scandinavica.

[21]  J. Sear,et al.  Continuous infusions of propofol administered to dogs: effects on ICG and propofol disposition. , 1994, British journal of anaesthesia.

[22]  H F Nicodemus,et al.  The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches , 1994, Anesthesiology.

[23]  B. Braverman,et al.  Propofol, but Not Thiopental, Supports the Growth of Candida albicans , 1995, Anesthesia and analgesia.

[24]  D M Perrotta,et al.  Postoperative infections traced to contamination of an intravenous anesthetic, propofol. , 1995, The New England journal of medicine.

[25]  A. Burm,et al.  Performance of Computer-Controlled Infusion of Propofol: An Evaluation of Five Pharmacokinetic Parameter Sets , 1995, Anesthesia and analgesia.

[26]  S. Shafer,et al.  Derivation and Cross-validation of Pharmacokinetic Parameters for Computer-controlled Infusion of Lidocaine in Pain Therapy , 1996, Anesthesiology.

[27]  S L Shafer,et al.  Pharmacokinetics of Propofol in Adult Patients Undergoing Coronary Revascularization , 1996, Anesthesiology.

[28]  D. Shen,et al.  Effects of Combining Propofol and Alfentanil on Ventilation, Analgesia, Sedation, and Emesis in Human Volunteers , 1996, Anesthesiology.

[29]  C A Shanks,et al.  Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly. , 1996, The Journal of pharmacology and experimental therapeutics.

[30]  Thomas W. Schnider,et al.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development , 1997 .